223 related articles for article (PubMed ID: 27181615)
41. Integrating basophil activation tests into evaluation of perioperative anaphylaxis to neuromuscular blocking agents.
Li J; Best OG; Rose MA; Green SL; Fulton RB; Fernando SL
Br J Anaesth; 2019 Jul; 123(1):e135-e143. PubMed ID: 30954238
[TBL] [Abstract][Full Text] [Related]
42. Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis.
Mukai K; Gaudenzio N; Gupta S; Vivanco N; Bendall SC; Maecker HT; Chinthrajah RS; Tsai M; Nadeau KC; Galli SJ
J Allergy Clin Immunol; 2017 Mar; 139(3):889-899.e11. PubMed ID: 27527263
[TBL] [Abstract][Full Text] [Related]
43. Update on the performance and application of basophil activation tests.
McGowan EC; Saini S
Curr Allergy Asthma Rep; 2013 Feb; 13(1):101-9. PubMed ID: 23188565
[TBL] [Abstract][Full Text] [Related]
44. Increased level of basophil CD203c expression predicts severe chronic urticaria.
Ye YM; Yang EM; Yoo HS; Shin YS; Kim SH; Park HS
J Korean Med Sci; 2014 Jan; 29(1):43-7. PubMed ID: 24431904
[TBL] [Abstract][Full Text] [Related]
45. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
46. A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils.
Iwamoto T; Okamoto A; Ishinaga H; Shimizu K; Gayle AA; Arai N; Takeuchi K; Okuda M
Cancer Med; 2016 Jun; 5(6):1004-12. PubMed ID: 26880699
[TBL] [Abstract][Full Text] [Related]
47. Drug allergy.
Honsinger RW
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):111. PubMed ID: 15328668
[No Abstract] [Full Text] [Related]
48. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy.
Zanotti KM; Rybicki LA; Kennedy AW; Belinson JL; Webster KD; Kulp B; Peterson G; Markman M
J Clin Oncol; 2001 Jun; 19(12):3126-9. PubMed ID: 11408510
[TBL] [Abstract][Full Text] [Related]
49. Higher allergenicity of high molecular weight hydrolysed wheat protein in cosmetics for percutaneous sensitization.
Chinuki Y; Takahashi H; Dekio I; Kaneko S; Tokuda R; Nagao M; Fujisawa T; Morita E
Contact Dermatitis; 2013 Feb; 68(2):86-93. PubMed ID: 23205470
[TBL] [Abstract][Full Text] [Related]
50. Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
Wu HL
J Oncol Pharm Pract; 2019 Sep; 25(6):1388-1395. PubMed ID: 30176784
[TBL] [Abstract][Full Text] [Related]
51. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui T; Masuda S; Yamaguchi M; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():47-53. PubMed ID: 18504407
[TBL] [Abstract][Full Text] [Related]
52. Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity.
Markman M; Zanotti K; Kulp B; Peterson G; Markman M
Gynecol Oncol; 2003 Jun; 89(3):514-6. PubMed ID: 12798720
[TBL] [Abstract][Full Text] [Related]
53. Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: the first report of a case.
Shukunami K; Kurokawa T; Kawakami Y; Kubo M; Kotsuji F
Gynecol Oncol; 1999 Mar; 72(3):431-2. PubMed ID: 10053120
[TBL] [Abstract][Full Text] [Related]
54. Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells.
Tsai SH; Takeda K
Semin Immunopathol; 2016 Sep; 38(5):571-9. PubMed ID: 27130555
[TBL] [Abstract][Full Text] [Related]
55. Utility of delayed reading of intradermal test in carboplatin-induced drug hypersensitivity.
D'Amelio CM; Aramendía JM; Yuste JR; Fusco JP; Gastaminza G; Goikoetxea MJ
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):534-5. PubMed ID: 26021896
[No Abstract] [Full Text] [Related]
56. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
57. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
Markman M; Zanotti K; Peterson G; Kulp B; Webster K; Belinson J
J Clin Oncol; 2003 Dec; 21(24):4611-4. PubMed ID: 14673050
[TBL] [Abstract][Full Text] [Related]
58. Basophil-activation tests in Hymenoptera allergy.
Dubois AE; van der Heide S
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):346-9. PubMed ID: 17620828
[TBL] [Abstract][Full Text] [Related]
59. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
Platz IJ; Binder M; Marxer A; Lischka G; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2001 Dec; 126(4):335-42. PubMed ID: 11815741
[TBL] [Abstract][Full Text] [Related]
60. Anaphylactic reaction to carboplatin diagnosed by skin testing-a reliable tool in platinum-based immediate-type hypersensitivity reactions.
Marquart E; Jalili A; Mothes-Luksch N; Wagner SN; Kinaciyan T
Wien Med Wochenschr; 2023 Sep; 173(11-12):256-259. PubMed ID: 35595936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
